2 Popular Robinhood Stocks I Wouldn't Buy With Free Money
Robinhood Markets is the company behind investing platform Robinhood. Particularly popular among younger generations, Robinhood has received a lot of praise because of its efforts to "democratize finance." Thanks to its app, many who had never invested in stocks before are now actively doing so. Considering the stock market remains one of the best wealth generators for the common person, that is not a bad thing.
With that said, Robinhood investors aren't perfect, and while the company's list of the 100 most popular stocks on the platform features some excellent picks, others aren't so great. Here are two popular Robinhood stocks I wouldn't buy with free money: Ocugen (NASDAQ: OCGN) and Inovio Pharmaceuticals (NASDAQ: INO).
Ocugen -- a clinical-stage biotech, meaning it currently has no commercialized products -- is playing catch-up in the coronavirus vaccine market. That's not necessarily a losing strategy, particularly for a company this size; its current market cap only stands at $1.45 billion. There remains some white space in the COVID-19 vaccine market, especially in developing countries and given the advent of newer variants of the disease.
Source Fool.com